208 research outputs found

    SEPTIC SHOCK IN PATIENT WITH DISSEMINATED HISTOPLASMOSIS ASSOCIATED WITH AIDS: A CASE REPORT

    Get PDF
    SUMMARY Histoplasmosis is a systemic mycosis caused by Histoplasma capsulatum, which may present itself as a serious infection in immunocompromised individuals. We present a case of 31-year-old female with newly diagnosed HIV infection and history of fever, general and respiratory symptoms and diffuse hyperchromic papules through the body. She was admitted, with rapid progression to septic shock, and the presence of neutrophils filled with yeast-like organisms was detected on peripheral blood smear hematoscopia on the third day of hospitalization. The following is a brief review on the clinical picture and management of histoplasmosis

    Synthesis and characterization of new Ti–Bi2O3 anode and its use for reactive dye degradation

    Get PDF
    This paper reports the synthesis, characterization and application of a Ti–Bi2O3 anode for the electrochemical decolorization of the textile dye Reactive Red 2. The anode was synthesized by electrodeposition on a Ti substrate immersed in an acidic bismuth (III) solution at constant potential, followed by calcination in air at 600 °C. Thermogravimetric Analysis (TGA), Energy-dispersive X-ray spectroscopy (EDX) and X-ray diffraction (XRD) analysis revealed that the electrodeposited material was predominantly metallic bismuth, which was oxidized to pure α-Bi2O3 during the calcination in air. SEM micrographs revealed that the Bi2O3 coat at the anode surface was inhomogeneous and porous. Reactive Red 2 was completely electrochemically decolorized at the synthesized anode in the presence of H2O2. The applied current density, H2O2 and Na2SO4 concentration, medium pH and initial dye concentration affected the dye decolorization rate. The optimal process parameters were found to be as follows: an applied current density of 40 mA cm−2 using a mixture of 10 mmol dm−3 H2O2 and 10 mmol dm−3 Na2SO4 at pH 7. The dye decolorization rate was shown to decrease as its initial concentration increased. The decolorization reactions were found to follow pseudo-first order kinetics

    Whipple's disease: rare disorder and late diagnosis

    Full text link
    Whipple's disease is a rare systemic infectious disorder caused by the bacterium Tropheryma whipplei. We report the case of a 61-year-old male patient who presented to emergency room complaining of asthenia, arthralgia, anorexia, articular complaints intermittent diarrhea, and a 10-kg weight loss in one year. Laboratory tests showed the following results: Hb = 7.5 g/dL, albumin = 2.5 mg/dL, weight = 50.3 kg (BMI 17.4 kg/m²). Upper gastrointestinal endoscopy revealed areas of focal enanthema in the duodenum. An endoscopic biopsy was suggestive of Whipple's disease. Diagnosis was confirmed based on a positive serum polymerase chain reaction. Treatment was initiated with intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole. After one year of treatment, the patient was asymptomatic, with Hb = 13.5 g/dL, serum albumin = 5.3 mg/dL, and weight = 70 kg (BMI 24.2 kg/m²). Whipple's disease should be considered a differential diagnosis in patients with prolonged constitutional and/or gastrointestinal symptoms. Appropriate antibiotic treatment improves the quality of life of patients

    Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The transmissible spongiform encephalopathies (TSEs), otherwise known as the prion diseases, occur following the conversion of the normal cellular prion protein (PrP<sup>C</sup>) to an alternatively folded isoform (PrP<sup>Sc</sup>). The accumulation of PrP<sup>Sc </sup>within the brain leads to neurodegeneration through an unidentified mechanism. Since many neurodegenerative disorders including prion, Parkinson's and Alzheimer's diseases may be modified by cholesterol synthesis inhibitors, the effects of prion infection on the cholesterol balance within neuronal cells were examined.</p> <p>Results</p> <p>We report the novel observation that prion infection altered the membrane composition and significantly increased total cholesterol levels in two neuronal cell lines (ScGT1 and ScN2a cells). There was a significant correlation between the concentration of free cholesterol in ScGT1 cells and the amounts of PrP<sup>Sc</sup>. This increase was entirely a result of increased amounts of free cholesterol, as prion infection reduced the amounts of cholesterol esters in cells. These effects were reproduced in primary cortical neurons by the addition of partially purified PrP<sup>Sc</sup>, but not by PrP<sup>C</sup>. Crucially, the effects of prion infection were not a result of increased cholesterol synthesis. Stimulating cholesterol synthesis via the addition of mevalonate, or adding exogenous cholesterol, had the opposite effect to prion infection on the cholesterol balance. It did not affect the amounts of free cholesterol within neurons; rather, it significantly increased the amounts of cholesterol esters. Immunoprecipitation studies have shown that cytoplasmic phospholipase A<sub>2 </sub>(cPLA<sub>2</sub>) co-precipitated with PrP<sup>Sc </sup>in ScGT1 cells. Furthermore, prion infection greatly increased both the phosphorylation of cPLA<sub>2 </sub>and prostaglandin E<sub>2 </sub>production.</p> <p>Conclusion</p> <p>Prion infection, or the addition of PrP<sup>Sc</sup>, increased the free cholesterol content of cells, a process that could not be replicated by the stimulation of cholesterol synthesis. The presence of PrP<sup>Sc </sup>increased solubilisation of free cholesterol in cell membranes and affected their function. It increased activation of the PLA<sub>2 </sub>pathway, previously implicated in PrP<sup>Sc </sup>formation and in PrP<sup>Sc</sup>-mediated neurotoxicity. These observations suggest that the neuropathogenesis of prion diseases results from PrP<sup>Sc </sup>altering cholesterol-sensitive processes. Furthermore, they raise the possibility that disturbances in membrane cholesterol are major triggering events in neurodegenerative diseases.</p
    corecore